Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus
Background and aims: Bromocriptine is a dopaminergic (D2) agonist that has shown hypoglycemic and normotensive activity in preclinical and clinical studies. The main objective of this study was to investigate the effect of bromocriptine plus metformin on glycaemia and blood pressure in patients with...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-03-01
|
Series: | Romanian Journal of Diabetes Nutrition and Metabolic Diseases |
Subjects: | |
Online Access: | https://doi.org/10.2478/rjdnmd-2018-0006 |